MainStreet Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Buy
2,519
+61
+2% +$62.3K 0.41% 65
2026
Q1
$2.26M Buy
2,458
+286
+13% +$290K 0.34% 69
2025
Q4
$2.33M Buy
2,172
+277
+15% +$265K 0.34% 66
2025
Q3
$1.45M Buy
+1,895
New +$1.41M 0.19% 89
2024
Q2
Sell
-848
Closed -$660K 175
2024
Q1
$660K Buy
+848
New +$603K 0.08% 114
2023
Q4
Sell
-848
Closed -$455K 183
2023
Q3
$455K Sell
848
-474
-36% -$244K 0.05% 135
2023
Q2
$620K Sell
1,322
-28
-2% -$11.7K 0.07% 120
2023
Q1
$464K Buy
+1,350
New +$455K 0.05% 136
2020
Q3
Sell
-16,861
Closed -$2.77M 211
2020
Q2
$2.77M Buy
16,861
+11,838
+236% +$1.82M 0.19% 83
2020
Q1
$697K Buy
+5,023
New +$690K 0.09% 126

Other funds holding LLY

MainStreet Investment Advisors's LLY Position: Q2 2026 in Review

MainStreet Investment Advisors increased its Eli Lilly (LLY) stake by 2.5% in Q2 2026, buying an estimated $62.3K and bringing the position to 2,519 shares worth $3.02M. The position accounts for 0.41% of the portfolio, ranked #65.

MainStreet Investment Advisors first reported a position in LLY in Q1 2020 and has held it in 10 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • MainStreet Investment Advisors held 2,519 shares of Eli Lilly worth $3.02M as of Q2 2026.
  • MainStreet Investment Advisors bought 61 Eli Lilly shares in Q2 2026, an estimated $62.3K.
  • Eli Lilly made up 0.41% of MainStreet Investment Advisors's portfolio in Q2 2026, its #65 holding.
  • MainStreet Investment Advisors first reported a position in Eli Lilly in Q1 2020 and has held it in 10 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on MainStreet Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.